ALFA Finder
18:03 IST
BSE
Bonus Issue
Concord Biotech Bonus Issue
Concord Biotech allotted 10,46,16,204 bonus shares in a 1:1 ratio. Total equity shares rise to 20,92,32,408 after the bonus allotment.
Concord Biotech Ltd
- Share price
- ₹597.20
- Market cap
- ₹12,495 Cr
- Revenue (annual)
- ₹1,055 Cr
- Net profit (annual)
- ₹260.9 Cr
- P/E (TTM)
- 44.2×Sector 43.8×
- Promoter holding
- 44.09%+0.01% QoQ
- FII holding
- 7.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 7Bonus Issue 5Other Announcement 4Financial Results 4Board Meeting Date 4Regulatory Approval 3Business Update 2Annual General Meeting 2Management Change 1Legal & Regulatory 1Dividend 1Annual Report 1
Time
5 announcements with these filters
19:27 IST
BSE
Bonus Issue
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
18:00 IST
BSE
Bonus Issue
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
17:37 IST
BSE
Bonus Issue
Concord Biotech Bonus Issue
Concord Biotech's board recommended a 1:1 bonus share issue from free reserves. Shareholders will consider this proposal at an upcoming postal ballot on October 24, 2026.
17:07 IST
BSE
Bonus Issue
Concord Biotech Bonus Issue
Concord Biotech approved a 1:1 bonus issue of 10.46 crore equity shares. The board also increased the company's authorized share capital to Rs. 22 Crore.
- Value
- ₹10.46 Cr